Condition: Schizophrenia · Psychosis · Psychotic Disorders · Sponsor: University of Toronto
It is currently unknown what factors predict response to Cognitive Behavioural Therapy for Psychosis (CBTp) or Cognitive Remediation Therapy (CR) among individuals with schizophrenia-spectrum disorders, thus the current trial will examine predictors of response to determine who requires the combined intervention and who might respond sufficiently to either monotherapy.
This description comes directly from the study's public registry record.
Hanna Hamzai, HBSc · 6476896098 · hanna.hamzai@mail.utoronto.ca
Mike W Best, PhD, C.Psych · 6476014551 · m.best@utoronto.ca
Always discuss trial participation with your own doctor first.
| University of Toronto Scarborough | Scarborough Village, Ontario, Canada | Recruiting |
| Ontario Shores Centre for Mental Health Sciences (Ontario Shores) | Whitby, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05731414